GSK · LONDON STOCK EXCHANGE ·
GSK plc
FDA approves Nelkarmi for pretreated ALK+ NSCLC
Our AI’s take
The FDA granted accelerated approval to Nelkarmi for adults with locally advanced or metastatic ALK-positive non-small cell lung cancer who received either…
The full digestion is for members. What is good, what is bad and why, the numbers that matter, and the chart, then ask about it by voice or text.
Join freeNew to announcements? Learn what an RNS is and why prices move.